Literature DB >> 23109038

Cytomegalovirus: prophylaxis, preemption, or "wait and watch".

Shmuel Shoham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23109038      PMCID： PMC4039348          DOI： 10.1002/lt.23564

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  4 in total

1.  The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.

Authors:  M J George; D R Snydman; B G Werner; J Griffith; M E Falagas; N N Dougherty; R H Rubin
Journal:  Am J Med       Date:  1997-08       Impact factor: 4.965

2.  Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients.

Authors:  Andre C Kalil; Josh Levitsky; Elizabeth Lyden; Julie Stoner; Alison G Freifeld
Journal:  Ann Intern Med       Date:  2005-12-20       Impact factor: 25.391

3.  Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.

Authors:  Manav Wadhawan; Subash Gupta; Neerav Goyal; Karisangal R Vasudevan; Kausar Makki; Reetika Dawar; Raman Sardana; Nand Lal; Ajay Kumar
Journal:  Liver Transpl       Date:  2012-12       Impact factor: 5.799

4.  The pathogenesis of hepatitis C virus is influenced by cytomegalovirus.

Authors:  Raymund R Razonable; Kelly W Burak; Hester van Cruijsen; Robert A Brown; Michael R Charlton; Thomas F Smith; Mark J Espy; Walter Kremers; Jennie A Wilson; Cynthia Groettum; Russell Wiesner; Carlos V Paya
Journal:  Clin Infect Dis       Date:  2002-09-26       Impact factor: 9.079
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.